Back
Bright Minds Biosciences, Inc. 10K Form
Sell
45
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$71.89
Seasonality Move:
-15.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DRUG News And Ratings
See the #1 stock for the next 7 days that we like better than DRUG
DRUG Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.36 |
| Price / Book: | 10.76 |
Profitability
| EPS (TTM): | -1.93960 |
|---|---|
| Net Income (TTM): | $-14.2M |
| Gross Margin: | $-55K |
| Return on Equity: | -29.53% |
| Return on Assets: | -29.02% |
Bright Minds Biosciences, Inc. Earnings Forecast
Key Bright Minds Biosciences, Inc. Financial Ratios
-
Per Share Earnings over the last 7 years have been positive in 2 years.
Bright Minds Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DRUG |
| Website: | brightmindsbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 57.37 |
| Quick Ratio: | 56.27 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DRUG Technical Analysis vs Fundamental Analysis
Sell
45
Bright Minds Biosciences, Inc. (DRUG)
is a Sell
Is Bright Minds Biosciences, Inc. a Buy or a Sell?
-
Bright Minds Biosciences, Inc. stock is rated a SellThe current Bright Minds Biosciences, Inc. [DRUG] share price is $71.46. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.